Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by abpagton May 14, 2013 2:50am
282 Views
Post# 21396488

calculations for reminder of year at gold 1425

calculations for reminder of year at gold 1425

average gold price q1 1576

voor Q2 we take 1425

net cash flow q1 24,3 milj - 13,6 milj capital makes 10,7 what is terrific !

 

revenues and costs q2:

so difference of about 150$/ouce multipled by 27000 ouces makes 4milj. less revenue.

we believe cash cost wil be between 650-700 so we calculate 630+50=680 is around 1,3 milj in extra cost in q2

 

capital spending q2:

for q1 was 13,9 milj reminder of year 37,9 / 3 quaters left=12,6 milj per quater so 1,3 milj less than in q1

 

so net cash flow for q2 and reminder of yer per quater at gold 1425 (q1 1576) and production at 27000 (q1 27...) and cahs cost at 680 (q1 630)

24,3 milj - 5,3 milj + 1,3 =20,3 milj. - (37,9 / 3 capital) = 7,7 milj net cash flow !

 

even at worst case senario of gold at 1200 what will bankrupt al lot of gold companies and will drive supply down by a lot so good for the ones that are left over

 

so worst case senario 1425 to 1200 makes 225 $/ounces difference so per quater

makes 27000*225=6 milj in cash flow and net cash flow

this still leaves the company with net cash flow of 1,7 milj per quarter !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

this company is a beauty in compared to 60-80% of the other ones in the sector

 

 

earnings prognosis 

based on above calculations at 1425/27000/680 earnings will drop with 4 milj in q4

q1 13,6 milj / 231 milj shares makes 0,058 cents so 0,06 cents q1

q2 13,6-4 milj / 231 makes 0,042 cents so 0,04 cents q2

 

worst case senerio gold at 1200/27000/680

makes 13,6- 4 (drop from 1576 to 1425 and 630 to 680) - 6 (drop from 1425 to 1200) = earnings of 3,6 milj

so 3,6 milj / 231 makes 0,0156 cents ! still earning money

 

so bottem line for the year

at 1425$ and 680

Q1 6c  Q2 4c Q3 4c QQ 4c = 18 cents for 2013 multipled by 10 = 1,8 $ "possible" target price !

 

at 1425$ and 680 and 1200$ and 680 starting from Q3

Q1 6c Q2 4c Q3 1,5c QQ 1,5c = 13 cents for 2013 multipled by 10 = 1,3 $ "possible" target price !

 

this company is a steal and should have a rerating !

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bullboard Posts